Carregant...
Comparison of Pharmacokinetics of Aprepitant in Healthy Chinese and Caucasian Subjects
PURPOSE: Aprepitant is used to prevent nausea and vomiting associated with moderately and highly emetogenic chemotherapy. In this open-label, 2-period study, the safety, tolerability, and pharmacokinetics (PK) of aprepitant (EMEND(®)) were evaluated in healthy Chinese and Caucasian subjects. PATIENT...
Guardat en:
| Publicat a: | Drug Des Devel Ther |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7102878/ https://ncbi.nlm.nih.gov/pubmed/32273684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S243924 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|